Free Trial

Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Up - Still a Buy?

Aveanna Healthcare logo with Medical background

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $4.81, but opened at $5.18. Aveanna Healthcare shares last traded at $5.24, with a volume of 54,716 shares trading hands.

Analysts Set New Price Targets

Several brokerages recently weighed in on AVAH. Royal Bank of Canada raised their price target on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a "sector perform" rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a "buy" rating in a research note on Friday, August 9th. Finally, UBS Group increased their price objective on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a "sell" rating in a research note on Friday, August 9th.

View Our Latest Report on Aveanna Healthcare

Aveanna Healthcare Stock Performance

The stock has a market cap of $1.10 billion, a PE ratio of -8.02 and a beta of 2.13. The company's 50 day simple moving average is $5.13 and its 200 day simple moving average is $3.89.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.03. The company had revenue of $504.96 million for the quarter, compared to analysts' expectations of $494.02 million. Equities research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.09 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Creative Planning boosted its holdings in Aveanna Healthcare by 21.3% in the 3rd quarter. Creative Planning now owns 48,502 shares of the company's stock valued at $252,000 after purchasing an additional 8,502 shares during the period. Bank of New York Mellon Corp boosted its holdings in Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company's stock valued at $413,000 after purchasing an additional 9,243 shares during the period. Mackenzie Financial Corp boosted its holdings in Aveanna Healthcare by 35.9% in the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company's stock valued at $126,000 after purchasing an additional 12,075 shares during the period. Acadian Asset Management LLC boosted its holdings in Aveanna Healthcare by 185.6% in the 1st quarter. Acadian Asset Management LLC now owns 29,385 shares of the company's stock valued at $72,000 after purchasing an additional 19,096 shares during the period. Finally, SG Americas Securities LLC bought a new position in Aveanna Healthcare in the 3rd quarter valued at $101,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Aveanna Healthcare right now?

Before you consider Aveanna Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.

While Aveanna Healthcare currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines